Form 4: Tempus AI Director David Epstein Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
David Epstein, a director at Tempus AI, sold 370 shares of Class A Common Stock on May 1, 2025, at a price of $53.5 per share, according to a Form 4 filing with the SEC.
Summary
- On May 1, 2025, David Epstein, a director of Tempus AI, Inc., sold 370 shares of Class A Common Stock.
- The sale was executed at a price of $53.5 per share.
- The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on August 27, 2024.
- Following the transaction, Epstein directly owns 25,914 shares of Tempus AI's Class A Common Stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction under a pre-existing trading plan, with no indication of positive or negative implications for the company.
Industry Context
Sales by insiders are a normal part of corporate activity. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific inside information at the time of the transaction.
Comparison to Industry Standards
- Rule 10b5-1 trading plans are a common practice among corporate insiders to diversify their holdings and avoid accusations of trading on non-public information.
- The volume of shares sold (370) is relatively small compared to the total holdings (25,914), suggesting this is likely a routine diversification move rather than a significant divestment.
Stakeholder Impact
- The sale of shares by a director could have a minor psychological impact on shareholders, but the use of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 08/27/2024 | Date of adoption of Rule 10b5-1 trading plan |
| 05/01/2025 | Date of transaction (sale of shares) |
| 05/05/2025 | Date of signature on the Form 4 filing |
Keywords
Form 4, Tempus AI, David Epstein, Class A Common Stock, SEC Filing, 10b5-1 Trading Plan, Director, Share Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.